Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Receives $24.36 Consensus PT from Analysts

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has been given a consensus recommendation of “Reduce” by the fifteen brokerages that are presently covering the stock, MarketBeat Ratings reports. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $24.36.

WBA has been the topic of a number of recent research reports. SVB Leerink cut their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a research note on Monday, March 18th. Morgan Stanley cut their price target on Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating on the stock in a research note on Monday, April 1st. Barclays initiated coverage on Walgreens Boots Alliance in a research note on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 price target on the stock. Truist Financial reissued a “hold” rating and set a $25.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. Finally, Leerink Partnrs restated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Monday, February 26th.

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA opened at $18.05 on Friday. The stock’s 50-day simple moving average is $20.26 and its 200 day simple moving average is $21.86. The firm has a market capitalization of $15.57 billion, a PE ratio of -2.58, a price-to-earnings-growth ratio of 1.13 and a beta of 0.73. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50. Walgreens Boots Alliance has a twelve month low of $17.51 and a twelve month high of $35.54.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The business had revenue of $37.05 billion for the quarter, compared to analyst estimates of $35.86 billion. During the same period last year, the firm posted $1.16 earnings per share. Walgreens Boots Alliance’s revenue was up 6.3% compared to the same quarter last year. On average, analysts anticipate that Walgreens Boots Alliance will post 3.23 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Valerie B. Jarrett acquired 4,456 shares of Walgreens Boots Alliance stock in a transaction on Monday, January 29th. The stock was purchased at an average price of $22.44 per share, with a total value of $99,992.64. Following the completion of the purchase, the director now owns 4,456 shares of the company’s stock, valued at approximately $99,992.64. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, Director Inderpal S. Bhandari bought 3,000 shares of the business’s stock in a transaction that occurred on Thursday, April 11th. The shares were bought at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the transaction, the director now directly owns 3,000 shares in the company, valued at $54,150. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Valerie B. Jarrett bought 4,456 shares of the business’s stock in a transaction that occurred on Monday, January 29th. The shares were bought at an average cost of $22.44 per share, for a total transaction of $99,992.64. Following the transaction, the director now owns 4,456 shares of the company’s stock, valued at $99,992.64. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 13,456 shares of company stock worth $270,423. 17.40% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Highlander Capital Management LLC purchased a new position in Walgreens Boots Alliance in the fourth quarter worth $26,000. Pineridge Advisors LLC bought a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at $26,000. Venturi Wealth Management LLC raised its stake in shares of Walgreens Boots Alliance by 1,241.8% in the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 981 shares during the period. EverSource Wealth Advisors LLC raised its stake in shares of Walgreens Boots Alliance by 308.4% in the third quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 845 shares during the period. Finally, Rocky Mountain Advisers LLC bought a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at $30,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.